Adult Intraventricular Hemorrhage Market Report 2026

The adult intraventricular hemorrhage market size has grown strongly in recent years. It will grow from $2.22 billion in 2025 to $2.35 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing incidence of stroke and brain trauma, rising awareness of neurological disorders, limited availability of advanced neurosurgical devices, adoption of conventional ivh management protocols, growing hospital and specialty clinic infrastructure.

The adult intraventricular hemorrhage market size is expected to see strong growth in the next few years. It will grow to $2.9 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to development of minimally invasive surgical devices, increasing use of smart monitoring technologies, rising adoption of novel hemostatic and neuroprotective drugs, expansion of ivh-focused clinical research, growing demand for homecare and ambulatory intervention solutions. Major trends in the forecast period include rising adoption of external ventricular drainage (evd) systems, increasing use of minimally invasive neurosurgical tools, growing demand for hemostatic and antihypertensive drugs, expansion of advanced intracranial monitoring devices, focus on rapid diagnosis and early intervention in ivh.

The rising incidence of strokes is expected to drive the growth of the adult intraventricular hemorrhage market going forward. A stroke is a medical emergency that occurs when blood flow to the brain is interrupted or reduced, resulting in damage to brain cells. The increasing incidence of strokes is largely driven by factors such as an aging population, higher prevalence of hypertension, diabetes, and obesity, as well as lifestyle-related risks like smoking and physical inactivity. Strokes can lead to adult intraventricular hemorrhage (IVH) by causing bleeding within the brain's ventricular system, often due to ruptured blood vessels. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based independent statutory government agency, approximately 41,100 stroke incidents were recorded in Australia in 2023, averaging around 113 cases per day. Therefore, the rising incidence of strokes is propelling the growth of the adult intraventricular hemorrhage market.

Major companies operating in the adult intraventricular hemorrhage market are focusing on developing innovative solutions, such as neuroaccess devices, for the neurovascular management of ischemic and hemorrhagic strokes. Neuroaccess devices are medical instruments used to access the brain or spinal cord for diagnostic or therapeutic procedures. For instance, in June 2024, Penumbra Inc., a US-based medical device company, announced CE Mark approval and the European launch of its BMX81 and BMX96 neuroaccess devices for managing ischemic and hemorrhagic strokes. These devices are designed for neurovascular management of ischemic and hemorrhagic strokes and represent Penumbra’s most advanced neuroaccess offerings. Unlike traditional access catheters, the BMX81 and BMX96 utilize laser-cut stainless steel hypo tube technology, providing stability and trackability that allow physicians to navigate the brain’s complex anatomy with ease.

In April 2024, Viz.ai, a US-based digital health company, partnered with Nico Corporation to improve the treatment of intracerebral hemorrhage. Through this collaboration, Viz.ai aims to integrate Nico’s surgical and monitoring devices with its AI-powered stroke care platform, enhancing timely diagnosis, intervention, and patient outcomes in hemorrhagic stroke cases. Nico Corporation is a US-based medical technology company specializing in neurosurgical devices and monitoring solutions for managing intracerebral and intraventricular hemorrhages.

Major companies operating in the adult intraventricular hemorrhage market are Johnson and Johnson, Abbott Laboratories, Medtronic Plc, Siemens Healthineers, Medline Industries, Philips Healthcare Inc., Stryker Corporation, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Alcon Inc., Zimmer Biomet Holdings Inc., Olympus Corporation, Smith and Nephew, Kaneka Corporation, Karl Storz SE and Co. KG, Carl Zeiss Meditec AG, Integra Lifesciences Holdings Corp, Elekta AB, Leica Microsystems GmbH, KLS Martin Group, Natus Medical Incorporated, Aesculap Inc., NeuroPace Inc., Sophysa USA Inc, Spiegelberg GmbH and Co. KG, Vivonics Inc.

North America was the largest region in the adult intraventricular hemorrhage market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult intraventricular hemorrhage market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the adult intraventricular hemorrhage market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the adult intraventricular hemorrhage market by increasing costs for imported surgical devices, monitoring equipment, and specialized drugs. Segments like external ventricular drainage systems and advanced intracranial pressure monitors are most affected, with north america, europe, and asia-pacific research and healthcare hubs facing higher procurement costs. This has led to increased treatment expenses and supply chain adjustments. On the positive side, tariffs encourage local manufacturing of devices and drugs, promoting innovation and self-sufficiency in domestic healthcare markets.

The adult intraventricular hemorrhage market research report is one of a series of new reports that provides adult intraventricular hemorrhage market statistics, including adult intraventricular hemorrhage industry global market size, regional shares, competitors with a adult intraventricular hemorrhage market share, detailed adult intraventricular hemorrhage market segments, market trends and opportunities, and any further data you may need to thrive in the adult intraventricular hemorrhage industry. This adult intraventricular hemorrhage market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adult intraventricular hemorrhage (IVH) is a type of bleeding that occurs within the brain's ventricular system, where cerebrospinal fluid is produced and circulates. It often results from trauma, stroke, or other conditions that cause rupture of blood vessels in the brain. IVH can lead to increased intracranial pressure, hydrocephalus, and neurological damage, requiring prompt medical intervention.

The main product types for adult intraventricular hemorrhage are surgical devices, drugs, and monitoring devices. Surgical devices are specialized instruments used during surgeries to perform specific functions or achieve targeted outcomes in medical procedures. These products are distributed through various channels, including direct sales, distributors, online platforms, and others, and are applied in conditions such as intraventricular hemorrhage, intracerebral hemorrhage, subarachnoid hemorrhage, and others. They are utilized by various end-users, including hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers, and others.

The adult intraventricular hemorrhage market consists of revenues earned by entities by providing services such as neurological assessment and monitoring, physical therapy to regain motor skills and strength, and interventional radiology for endovascular procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The adult intraventricular hemorrhage market also includes sales of neuroendoscopic instruments, antiepileptic drugs, and osmotic diuretics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.